Form 4 for CLX Clorox
Accepted 2021-09-23 00:00:00 ET · period of report 2021-09-21 · accession 0001225208-21-012524 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-09-23 | 2021-09-21 | CLX | Grier Stacey | SVP - CMO | A - Grant | $163.77 | +976 | 3,081 | +46% | +$159.8K |
| D | 2021-09-23 | 2021-09-22 | CLX | Grier Stacey | SVP - CMO | F - Tax | $162.19 | -49 | 3,033 | -2% | -$7,947 |
| D | 2021-09-23 | 2021-09-21 | CLX | Grier Stacey | SVP - CMO | A - Grant | $0.00 | +7,183 | 7,183 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-21 | A | A | 976 | $163.77 | 3,081 | D | — | — | |
| 2 | Common | Common Stock | 2021-09-22 | F | D | 49 | $162.19 | 3,033 | D | — | — | (F3) Includes 1 share acquired pursuant to a dividend reinvestment feature of the Company's Stock Incentive Plan. |
| 3 | Derivative | Stock Option (Right to Buy) | 2021-09-21 | A | A | 7,183 | $0.00 | 7,183 | D | $163.77 · 2022-10-05 to 2022-09-21 | 7,183 Common Stock | (F4) Option vests in 4 equal installments on each of October 5 of 2022, 2023, 2024 and 2025. |